Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2022-03-22 Annual Report
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2021, covering the period from January 1, 2021, to December 31, 2021. It contains detailed company information, financial data, management discussions, and operational details, which is the standard format for an Annual Report (10-K equivalent in the Korean market). FY 2021
2022-03-22 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by DX&VX. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items.
2022-03-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings. Since this is a specific regulatory disclosure regarding meeting logistics and compliance with the KOSDAQ Association's guidelines, and does not fit into the specific categories of AGM materials, proxy statements, or voting results, it is best classified as a general regulatory filing.
2022-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for DXVX Co., Ltd. It includes the meeting date, location, agenda items (such as financial statement approval and director appointments), and detailed management information regarding business operations, market status, and board activities. This document is a standard proxy statement/notice of meeting sent to shareholders to inform them of the upcoming AGM and provide necessary background information for voting. In the context of the provided filing categories, this is classified as a Proxy Solicitation & Information Statement.
2022-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming General Meeting. It contains details about the meeting, the proxy solicitation process, and includes financial statements as reference material for shareholders. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-11 Korean
[기재정정]임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Extraordinary General Meeting (EGM) of shareholders, specifically detailing the voting outcomes for the appointment of directors and changes to the company's articles of association (including name change and business purpose updates). This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-12-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.